BioLineRx Ltd. (BLRX.TA)
ILA 5.8
(-9.38%)
ILA 5.8
(-9.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.91 Million USD | -23.53% |
| 2022 | 10.35 Million USD | 499.94% |
| 2021 | 1.72 Million USD | -60.78% |
| 2020 | 4.4 Million USD | -41.79% |
| 2019 | 7.56 Million USD | -3.53% |
| 2018 | 7.83 Million USD | 4892.36% |
| 2017 | 157 Thousand USD | -37.2% |
| 2016 | 250 Thousand USD | -27.33% |
| 2015 | 344 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 28.9 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 7.16 Million USD | -10.41% |
| 2024 Q2 | 20.09 Million USD | 216.44% |
| 2023 FY | 7.91 Million USD | -23.53% |
| 2023 Q2 | 10.08 Million USD | 1.43% |
| 2023 Q1 | 9.94 Million USD | -3.99% |
| 2023 Q3 | 9.7 Million USD | -3.72% |
| 2023 Q4 | 7.91 Million USD | -18.45% |
| 2022 Q1 | 1.65 Million USD | -3.94% |
| 2022 FY | 10.35 Million USD | 499.94% |
| 2022 Q4 | 10.35 Million USD | 5.02% |
| 2022 Q3 | 9.86 Million USD | 579.06% |
| 2022 Q2 | 1.45 Million USD | -12.42% |
| 2021 Q2 | 2.7 Million USD | -22.41% |
| 2021 Q1 | 3.48 Million USD | -20.72% |
| 2021 FY | 1.72 Million USD | -60.78% |
| 2021 Q4 | 1.72 Million USD | 2.86% |
| 2021 Q3 | 1.67 Million USD | -38.01% |
| 2020 Q3 | 5.15 Million USD | -13.49% |
| 2020 FY | 4.4 Million USD | -41.79% |
| 2020 Q1 | 6.71 Million USD | -11.19% |
| 2020 Q4 | 4.4 Million USD | -14.63% |
| 2020 Q2 | 5.95 Million USD | -11.26% |
| 2019 Q3 | 7.07 Million USD | -7.89% |
| 2019 Q2 | 7.67 Million USD | -8.12% |
| 2019 Q1 | 8.35 Million USD | 6.63% |
| 2019 FY | 7.56 Million USD | -3.53% |
| 2019 Q4 | 7.56 Million USD | 6.9% |
| 2018 Q3 | 86 Thousand USD | -21.1% |
| 2018 Q2 | 109 Thousand USD | -18.05% |
| 2018 Q1 | 133 Thousand USD | -15.29% |
| 2018 Q4 | 7.83 Million USD | 9013.95% |
| 2018 FY | 7.83 Million USD | 4892.36% |
| 2017 Q2 | 203 Thousand USD | -10.57% |
| 2017 Q4 | 157 Thousand USD | -12.78% |
| 2017 Q3 | 180 Thousand USD | -11.33% |
| 2017 Q1 | 227 Thousand USD | -9.2% |
| 2017 FY | 157 Thousand USD | -37.2% |
| 2016 Q2 | 296 Thousand USD | -7.5% |
| 2016 Q3 | 272 Thousand USD | -8.11% |
| 2016 Q4 | 250 Thousand USD | -8.09% |
| 2016 Q1 | 320 Thousand USD | -6.98% |
| 2016 FY | 250 Thousand USD | -27.33% |
| 2015 Q3 | 366 Thousand USD | 0.0% |
| 2015 Q4 | 344 Thousand USD | -6.01% |
| 2015 FY | 344 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q1 | 7537.32 USD | -73.92% |
| 2012 Q2 | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q3 | 51 Thousand USD | -35.8% |
| 2011 Q4 | 28.9 Thousand USD | -43.34% |
| 2011 FY | 28.9 Thousand USD | 0.0% |
| 2011 Q1 | 100.51 Thousand USD | 0.0% |
| 2011 Q2 | 79.44 Thousand USD | -20.97% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Matricelf Ltd | - ILA | -Infinity% |